Vivoryon Therapeutics NV
AEX:VVY

Watchlist Manager
Vivoryon Therapeutics NV Logo
Vivoryon Therapeutics NV
AEX:VVY
Watchlist
Price: 1.452 EUR 2.25% Market Closed
Market Cap: 43m EUR

Vivoryon Therapeutics NV
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Vivoryon Therapeutics NV
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Vivoryon Therapeutics NV
AEX:VVY
Operating Income
-€21m
CAGR 3-Years
-18%
CAGR 5-Years
-22%
CAGR 10-Years
-6%
BioNTech SE
NASDAQ:BNTX
Operating Income
-€1.2B
CAGR 3-Years
N/A
CAGR 5-Years
-45%
CAGR 10-Years
N/A
CureVac NV
NASDAQ:CVAC
Operating Income
€177.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Operating Income
-€142.2m
CAGR 3-Years
N/A
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Operating Income
€11.9m
CAGR 3-Years
N/A
CAGR 5-Years
-1%
CAGR 10-Years
-12%
Formycon AG
XETRA:FYB
Operating Income
-€23.5m
CAGR 3-Years
-19%
CAGR 5-Years
-60%
CAGR 10-Years
N/A
No Stocks Found

Vivoryon Therapeutics NV
Glance View

Market Cap
43m EUR
Industry
Biotechnology

The company is headquartered in Halle, Sachsen-Anhalt and currently employs 16 full-time employees. The company went IPO on 2014-10-27.

VVY Intrinsic Value
Not Available

See Also

What is Vivoryon Therapeutics NV's Operating Income?
Operating Income
-21m EUR

Based on the financial report for Dec 31, 2024, Vivoryon Therapeutics NV's Operating Income amounts to -21m EUR.

What is Vivoryon Therapeutics NV's Operating Income growth rate?
Operating Income CAGR 10Y
-6%

Over the last year, the Operating Income growth was 28%. The average annual Operating Income growth rates for Vivoryon Therapeutics NV have been -18% over the past three years , -22% over the past five years , and -6% over the past ten years .

Back to Top